The RACGP has welcomed government confirmation that GPs will be at the forefront of Australia's COVID-19 vaccine rollout.
Researchers have discovered how to revert antibiotic resistance in one of the most dangerous superbugs: Acinetobacter baumannii — responsible for up to 20% of infections in ICUs.
Australia's coronavirus vaccine rollout will be brought forward to next month, with Prime Minister Scott Morrison saying the first groups are expected to receive the jab in mid-to-late February.
Con-Serv has partnered with Biomaster to introduce a range of antimicrobial products, including showerheads, shower hoses, sliders and aerators.
Multidrug-resistant C. auris is an important emerging pathogen which demands attention and action when identified in the healthcare setting.
Recent months have seen growing demand for partition screens in many countries to ensure extra precaution and mitigate the risks of coronavirus infection among drivers.
Clinell Rediroom is an innovative alternative to increase the availability of additional isolation space to help prevent infections and save lives.
Interim results of the University of Oxford's COVID-19 vaccine Phase 3 trials find that the vaccine protects against symptomatic disease in 70% of cases on average.
A mobile or modular on-site sterilisation department can ensure continuity during periods of refurbishment or exceptional demand.
An instant patient isolation room that can be deployed in five minutes is being used by hospitals throughout the UK to isolate patients with COVID-19.
Older Australians may be missing out on protection against pertussis because GPs tend to focus on vaccinating those in close contact with young children.
Pfizer and BioNTech may face major hurdles in getting their vaccine to market, despite recently being touted as winners of the COVID-19 vaccine race.
An international team of human and animal health experts has identified areas at risk of harbouring the conditions that may lead to the next pandemic.
AstraZeneca's results signal more good vaccine news — but efficacy is only the beginning of the story.
The innovative project will integrate genomics, electronic healthcare data and AI technologies to address antimicrobial resistance in the healthcare system.